Immediate Impact
31 standout
Citing Papers
A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
2023 Standout
Antibody–drug conjugates come of age in oncology
2023 Standout
Works of Ìhsan Karadoǧan being referenced
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ìhsan Karadoǧan | 86 | 32 | 16 | 53 | 52 | 26 | 242 | |
| Güner Hayri Özsan | 86 | 32 | 3 | 51 | 80 | 31 | 217 | |
| Yao‐Chung Liu | 107 | 33 | 5 | 55 | 60 | 32 | 273 | |
| Athanasios Papadopoulos | 101 | 49 | 12 | 59 | 75 | 23 | 283 | |
| Iván Murrieta-Álvarez | 68 | 20 | 4 | 72 | 35 | 32 | 161 | |
| Yahveth Cantero‐Fortiz | 51 | 19 | 3 | 61 | 30 | 27 | 191 | |
| Chisaki Mizumoto | 128 | 86 | 13 | 31 | 67 | 33 | 270 | |
| Ali Younas Khan | 97 | 30 | 6 | 56 | 118 | 29 | 296 | |
| J Vantelon | 63 | 19 | 7 | 100 | 83 | 24 | 290 | |
| Nikolaos J. Tsagarakis | 52 | 56 | 12 | 33 | 68 | 23 | 267 | |
| Kadir Acar | 130 | 54 | 12 | 35 | 59 | 35 | 298 |
All Works
Loading papers...